Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
J.B.CHEMICALS TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
J.B.CHEMICALS Mar-23 |
TEVA PHARMA Dec-13 |
J.B.CHEMICALS/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2,150 | 3,486 | - | |
Low | Rs | 1,339 | 3,028 | - | |
Sales per share (Unadj.) | Rs | 407.0 | 2,000.5 | - | |
Earnings per share (Unadj.) | Rs | 53.0 | 125.0 | - | |
Cash flow per share (Unadj.) | Rs | 67.8 | 286.7 | - | |
Dividends per share (Unadj.) | Rs | 8.88 | 109.40 | - | |
Avg Dividend yield | % | 0.5 | 3.4 | 15.1% | |
Book value per share (Unadj.) | Rs | 304.8 | 2,222.2 | - | |
Shares outstanding (eoy) | m | 77.38 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 1.6 | 263.3% | |
Avg P/E ratio | x | 32.9 | 26.1 | 126.3% | |
P/CF ratio (eoy) | x | 25.7 | 11.4 | 226.6% | |
Price / Book Value ratio | x | 5.7 | 1.5 | 390.5% | |
Dividend payout | % | 16.7 | 87.5 | 19.1% | |
Avg Mkt Cap | Rs m | 134,983 | 2,761,843 | 4.9% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 5,435 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,744.4 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 31,493 | 1,696,422 | 1.9% | |
Other income | Rs m | 99 | 0 | - | |
Total revenues | Rs m | 31,592 | 1,696,422 | 1.9% | |
Gross profit | Rs m | 6,958 | 464,566 | 1.5% | |
Depreciation | Rs m | 1,144 | 137,123 | 0.8% | |
Interest | Rs m | 361 | 33,320 | 1.1% | |
Profit before tax | Rs m | 5,552 | 294,122 | 1.9% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,075 | -0.0% | |
Tax | Rs m | 1,452 | -3,591 | -40.4% | |
Profit after tax | Rs m | 4,100 | 105,974 | 3.9% | |
Gross profit margin | % | 22.1 | 27.4 | 80.7% | |
Effective tax rate | % | 26.2 | -1.2 | -2,142.4% | |
Net profit margin | % | 13.0 | 6.2 | 208.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 15,993 | 1,145,757 | 1.4% | |
Current liabilities | Rs m | 6,257 | 999,197 | 0.6% | |
Net working cap to sales | % | 30.9 | 8.6 | 357.8% | |
Current ratio | x | 2.6 | 1.1 | 222.9% | |
Inventory Days | Days | 85 | 91 | 93.8% | |
Debtors Days | Days | 667 | 96 | 695.8% | |
Net fixed assets | Rs m | 24,988 | 554,089 | 4.5% | |
Share capital | Rs m | 155 | 4,176 | 3.7% | |
Net worth | Rs m | 23,587 | 1,884,403 | 1.3% | |
Long term debt | Rs m | 3,832 | 867,418 | 0.4% | |
Total assets | Rs m | 40,981 | 3,876,868 | 1.1% | |
Interest coverage | x | 16.4 | 9.8 | 166.9% | |
Debt to equity ratio | x | 0.2 | 0.5 | 35.3% | |
Sales to assets ratio | x | 0.8 | 0.4 | 175.6% | |
Return on assets | % | 10.9 | 3.6 | 302.9% | |
Return on equity | % | 17.4 | 5.6 | 309.1% | |
Return on capital | % | 21.6 | 4.9 | 437.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,256 | 270,322 | 2.3% | |
From Investments | Rs m | -9,618 | -95,786 | 10.0% | |
From Financial Activity | Rs m | 3,565 | -324,269 | -1.1% | |
Net Cashflow | Rs m | 204 | -149,733 | -0.1% |
Compare J.B.CHEMICALS With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare J.B.CHEMICALS With: JAGSON PHAR DECCAN HEALTH CARE SYSCHEM (I). GUJ.THEMIS. MEDICO REMEDIES
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.